NCT06014164View on ClinicalTrials.gov

Qualitative Study About Psychedelics Using in Psychiatric Disorders

Not yet recruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

March 10, 2025

Study Completion Date

March 10, 2025

Conditions
Psychiatric Disorder
Interventions
DIAGNOSTIC_TEST

Interview

An interview will be conducted to describe the experiences of people with psychiatric disorders who use psychedelic substances for therapeutic purposes

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT06014164 - Qualitative Study About Psychedelics Using in Psychiatric Disorders | Biotech Hunter | Biotech Hunter